Market Size in 2019 | Market Forecast in 2026 | CAGR (in %) | Base Year |
---|---|---|---|
USD 927.9 Million | USD 1,601.6 Million | 8.2% | 2019 |
List of Figures
1. Market research process
2. Market research methodology
3. Global hunter syndrome treatment market, 2016 - 2026(USD Million)
4. Porter’s five forces analysis: hunter syndrome treatment market
5. Global hunter syndrome treatment market attractiveness, by treatment
6. Global hunter syndrome treatment market revenue share, by treatment, 2019 and 2026
7. Global hunter syndrome treatment market by Hematopoietic Stem Cell Transplant (HSCT), 2016 - 2026(USD Million)
8. Global hunter syndrome treatment market by Enzyme Replacement Therapy (ERT), 2016 - 2026(USD Million)
9. Global hunter syndrome treatment market by Others, 2016 - 2026(USD Million)
10. Global hunter syndrome treatment market revenue share, by region, 2018 & 2025
11. North America hunter syndrome treatment market, 2016 - 2026(USD Million)
12. Europe hunter syndrome treatment market, 2016 - 2026(USD Million)
13. Asia Pacific hunter syndrome treatment market, 2016 - 2026(USD Million)
14. Latin America hunter syndrome treatment market, 2016 - 2026(USD Million)
15. Middle East & Africa hunter syndrome treatment market, 2016 - 2026(USD Million)
List of Tables
1. Global hunter syndrome treatment market: snapshot
2. Drivers for hunter syndrome treatment market: impact analysis
3. Restraints for hunter syndrome treatment market: impact analysis
4. North America hunter syndrome treatment market revenue, by country, 2016 - 2026(USD Million)
5. North America hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
6. The U.S. hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
7. Rest of North America hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
8. Europe hunter syndrome treatment market revenue, by country, 2016 - 2026(USD Million)
9. Europe hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
10. U.K. hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
11. France hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
12. Germany hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
13. Rest of Europe hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
14. Asia Pacific hunter syndrome treatment market revenue, by country, 2016 - 2026(USD Million)
15. Asia Pacific hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
16. China hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
17. Japan hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
18. India hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
19. Rest of Asia Pacific hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
20. Latin America hunter syndrome treatment market revenue, by country, 2016 - 2026(USD Million)
21. Latin America hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
22. Brazil hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
23. Rest of Latin America hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
24. Middle East & Africa hunter syndrome treatment market revenue, by treatment, 2016 - 2026(USD Million)
FrequentlyAsked Questions
Hunter syndrome, commonly known as mucopolysaccharidosis II (MPS II), is a rare genetic condition characterized by iduronate-2-sulfatase deficiency. This deficit causes glycosaminoglycans to accumulate in cells, creating a variety of progressive and debilitating symptoms.
The global demand for hunter syndrome treatment market is driven by expected approval of new therapies, growing research and development activities, and extended life expectancy.
According to the report, global demand for hunter syndrome treatment market was valued at approximately USD 927.9 million in 2019, and is expected to generate revenue of around USD 1,601.6 million by end of 2026, growing at a CAGR of around 8.2% between 2020 and 2026.
North America held largest revenue share of the global hunter syndrome treatment market in 2018. This large share is attributed to government funding, growing awareness and presence of key players in this region.
Major players in hunter syndrome treatment market are GC Pharma, Takeda Pharmaceutical Company, RegenxBio Inc., JCR Pharmaceuticals Co Ltd., Sangamo Therapeutics, Inc., Inventiva S.A., ArmaGen Inc, Esteve, Bioasis Technologies Inc., and Denali Therapeutics Inc among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed